SCHEMBL12847190

SCHEMBL12847190

Cc1nc2cc(NC(=O)Oc3ccc(Br)cc3)ccc2c(=O)n1C(c1ccccc1)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ GAA P10253 2/20 0.39
▸ CCKBR P32239 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ MMP12 P39900 1/20 0.38
▸ MMP13 P45452 1/20 0.38
▸ PORCN Q9H237 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ BRD4 O60885 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ CYP1A2 P05177 1/20 0.36
▸ KIT P10721 1/20 0.36
▸ PDGFRA P16234 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12788563 0.94 ALDH1A1 (0.42) KMT2AALDH1A1GAAMEN1LMNA
SCHEMBL12788338 0.83 CA12 (0.43) KMT2AALDH1A1GAAMEN1TP53
SCHEMBL12788398 0.80 LMNA (0.45) KMT2AALDH1A1MEN1LMNAPOLB
SCHEMBL12788315 0.76 ACSS2 (0.46) KMT2AALDH1A1MEN1LMNAPOLB
SCHEMBL12788497 0.75 SMN1; SMN2 (0.51) ALDH1A1LMNAPOLBTSHRMAPK1
SCHEMBL12788833 0.74 MAPT (0.47) KMT2AALDH1A1MEN1LMNATP53
SCHEMBL12788397 0.74 KMT2A (0.51) KMT2AALDH1A1MEN1LMNAPOLB
SCHEMBL12788570 0.73 NPC1 (0.51) KMT2AALDH1A1GAAMEN1LMNA
SCHEMBL12788663 0.73 ALDH1A1 (0.48) KMT2AALDH1A1LMNAPOLBMAPT
SCHEMBL12788327 0.72 ALDH1A1 (0.47) KMT2AALDH1A1GAAMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065671-A1 BICYCLIC HETEROCYCLE DERIVATIVES AND USE THEREOF AS GPR119 MODULATORS MERCK SHARP & DOHME CORP. 2011-03-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065671-A1 BICYCLIC HETEROCYCLE DERIVATIVES AND USE THEREOF AS GPR119 MODULATORS GPR119, GPR39, GPR65 KMT2A 3444/4885ALDH1A1 833/4885GAA 2634/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback